No Prescription |
 |
 | ||
|
Seroquin Seroquel |
|
| ||
No Prescription » Prescription Drugs 15 » Seroquin Seroquel Quetiapine is an antipsychotic medication. It works by changing the actions of chemicals in the brain. Quetiapine is used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). Quetiapine is used for: Treating schizophrenia. It is also used to treat acute manic episodes associated with bipolar disorder (manic-depression). Bipolar DisorderQuetiapine is indicated for the treatment of both: Depressive episodes associated with bipolar disorder acute manic episodes associated with bipolar I disorder as either monotherapy or adjunct therapy to lithium or divalproex. Buy Seroquin Seroquel and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About Seroquin Seroquel: Product Type: Prescription Drugs 15 Seroquin ( Seroquel Generic Quetiapine Fumarate ) Seroquin (Seroquel Generic Quetiapine Fumarate) Seroquel Generic Quetiapine Fumarate 100mg 100 Tablets 100mg 200 Tablets 100mg 400 Tablets 200mg 100 Tablets 200mg 400 Tablets 200mg 200 Tablets 25mg 100 Tablets 25mg 400 Tablets 25mg 200 Tablets 300mg 200 Tablets 300mg 100 Tablets 300mg 50 Tablets 50mg 100 Tablets Seroquel Generic Quetiapine Fumarate Seroquin
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
